Intrinsic Value
Neoleukin Therapeutics, Inc. (NLTX)
$3.49
+0.05 (+1.45%)
| Enterprise Value | - |
|---|---|
| Net Debt | -25.82 |
| Equity Value | - |
| Shares Outstanding | 55.22 |
| Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt